Baogang Liu
Harbin Medical University · 116 works · 3,201 citations · h-index 26
Top works
- Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
- Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
- Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
- Overall Survival with Amivantamab–Lazertinib in EGFR -Mutated Advanced NSCLC
- Reversal of Peripheral Nerve Injury-induced Hypersensitivity in the Postpartum Period
- Acute Topical Application of Tumor Necrosis Factor α Evokes Protein Kinase A-Dependent Responses in Rat Sensory Neurons
- Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
- Inhibition of Ca2+-activated Cl− channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma
- Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study
- Increased Sensitivity of Sensory Neurons to Tumor Necrosis Factor α in Rats With Chronic Compression of the Lumbar Ganglia
- Diagnosis of intravenous leiomyomatosis extending to heart with emphasis on magnetic resonance imaging.
- Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial
- Estrogen Amplifies Pain Responses to Uterine Cervical Distension in Rats by Altering Transient Receptor Potential-1 Function
- Nitric Oxide Synthase Expressions in ADR-induced Cardiomyopathy in Rats
- Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial
- Pregnancy Increases Excitability of Mechanosensitive Afferents Innervating the Uterine Cervix
- miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1
- Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
- RETRACTED: MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN/PI3K/AKT pathway
- Hyperexcitability of Axotomized and Neighboring Unaxotomized Sensory Neurons Is Reduced Days After Perineural Clonidine at the Site of Injury